Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, November 6, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease
Life Sciences Times
-
October 27, 2025
Pharma
Zymeworks Reports Promising Early Data from Phase 1 Study of ZW191 Targeting Folate Receptor-Alpha in Advanced Solid Tumors
Life Sciences Times
-
October 24, 2025
Pharma
Verastem Oncology Reports Promising Early Results from Ongoing Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor
Life Sciences Times
-
October 24, 2025
Pharma
CDR-Life Reports Early Clinical Data Showing Pharmacodynamic Activity of CDR404 in MAGE-A4 Positive Solid Tumors
Life Sciences Times
-
October 24, 2025
0
Pharma
FDA Grants Priority Review for KEYTRUDA and KEYTRUDA QLEX, Each in Combination with Padcev, for Certain Patients with Muscle-Invasive Bladder Cancer
Life Sciences Times
-
October 23, 2025
0
Pharma
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma
Life Sciences Times
-
October 23, 2025
0
Pharma
USAntibiotics Receives FDA National Priority Voucher for Domestic Antibiotic Manufacturing
Life Sciences Times
-
October 22, 2025
0
Pharma
IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial
Life Sciences Times
-
October 17, 2025
0
Pharma
Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001
Life Sciences Times
-
October 17, 2025
0
Pharma
Delix Therapeutics Study Shows Non-Hallucinogenic Compound Zalsupindole Promotes Neuroplasticity Comparable to Ketamine and Psychedelics
Life Sciences Times
-
October 16, 2025
0
Pharma
Cycle Pharmaceuticals Launches PHYRAGO in U.S., Its First Oncology Treatment
Life Sciences Times
-
October 16, 2025
0
Pharma
ClearB Therapeutics Advances Phase 1b Trial of CLB-4000 for Chronic Hepatitis B Following Positive Safety Review
Life Sciences Times
-
October 15, 2025
0
Pharma
PeptiDream, PDRadiopharma and Curium Begin Phase 2 Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Life Sciences Times
-
October 15, 2025
0
Pharma
Alzheon Publishes Peer-Reviewed Results from Pivotal Phase 3 APOLLOE4 Trial of Oral Valiltramiprosate in APOE4/4 Homozygous Patients with Early Alzheimer’s Disease
Life Sciences Times
-
October 14, 2025
0
Pharma
Akamis Bio Receives FDA Fast Track Designation for NG-350A in Treatment of Locally Advanced Rectal Cancer
Life Sciences Times
-
October 14, 2025
0
1
2
3
...
82
Page 1 of 82
Most Read
ONDEX Automation Acquires PlantOPS Consulting to Expand Life Sciences Capabilities
November 5, 2025
Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development
November 5, 2025
VideaHealth and Henry Schein One Introduce Impact Panel for Dentrix and Dentrix Ascend
November 5, 2025
Harrison.ai Launches Zero-Markup Medical Imaging AI Platform
November 5, 2025